As Ukraine holds the line against the Russian invasion, pharma majors are making a renewed push to adjust operations in the region and supply the besieged country with critical meds and tools.
Swiss pharma Roche on Wednesday said it was donating additional drugs and diagnostics to Ukraine, building on 150,000 packs of antibiotics the company previously pledged. It says it’s adding to its commitment another 4,600 packs of specialized medicines for influenza, rheumatoid arthritis, spinal muscular atrophy and various cancers.
The company is also donating reagents and consumables for automatic testing “of up to 120,000 blood donations and 31,000 units for diabetes management.”
Roche says it’s committed to meet the need for its drugs and diagnostics in Ukraine “whenever possible.” It’s in touch with multiple global and local partners, plus charities, “to understand how to best continue to support the people of Ukraine with medical supplies,” the company said.
And Roche isn’t mincing words on the conflict: The company “vehemently condemns the violent invasion of Ukraine,” and “remains hopeful the war will reach a peaceful resolution as soon as possible.”
Israeli-American generic drugmaker Teva Pharmaceutical, for its part, has promised Ukraine more than $11 million in essential medical products for acute therapies “in humanitarian support of Ukrainian refugees,” the company said earlier this month.
Specifically, Teva will donate roughly 27 million doses of medicines in more than 1.3 million packs, with a value of more than $10.8 million, based on wholesale acquisition cost (WAC). Most of those donations have been made in tandem with Teva’s long-term partner Direct Relief. The company says many of the drugs it has donated are on the World Health Organization’s list of essential medicines. They include antibiotics, treatments for respiratory conditions and more.
In addition, Teva has donated more than 25,000 packs of antibiotics worth about $180,000 to Israeli non-profit emergency and relief organization United Hatzalah, the company said in a release. That aid specifically supports refugee camps and field hospitals on Ukraine’s borders, the company said. “The medicines arrived at the border of Ukraine last week and we are helping to treat thousands of refugees who have fled the war,” the company added.
The company is weighing additional donations programs throughout Europe and is keeping in contact with partners and international humanitarian aid organizations to “understand the emerging needs, and make a contribution through [its] expertise and supply chain,” the company noted.